Bright Minds Biosciences Inc. (DRUG) stock
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
$20.76+0.25 (+1.22%)
Close on Nov 18, 2026Market cap $158.52MP/E –Yield –
Bright Minds Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -C$8.69M. The highest annual figure on record is -C$288.39K in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -C$8.69M | – |
| FY2024 | Sep 30, 2024 | -C$1.85M | – |
| FY2023 | Sep 30, 2023 | -C$7.02M | – |
| FY2022 | Sep 30, 2022 | -C$13.59M | – |
| FY2021 | Sep 30, 2021 | -C$7.32M | – |
| FY2020 | Sep 30, 2020 | -C$288.39K | – |
See a number that looks wrong?